학술논문
Mirvetuximab soravtansine (MIRV) in patients with platinum-resistant ovarian cancer with high folate receptor alpha (FRα) expression: Evaluation of sequence of therapy on anti-tumor activity in the SORAYA study (002)
Document Type
Abstract
Author
Source
In Gynecologic Oncology September 2023 176 Supplement 1:S3-S3
Subject
Language
ISSN
0090-8258